Diabetes Medication Assistance Service Stage 1: impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetes (Q39770323)

14 September 2017

Diabetes Medication Assistance Service Stage 1: impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetes (English)

1 reference

14 September 2017

0 references

L Smith

7

0 references

Carol L Armour

object named as

C Armour

9

0 references

Ines Krass

object named as

I Krass

1

0 references

author name string

B Mitchell

2

1 reference

14 September 2017

Y J C Song

3

1 reference

14 September 2017

K Stewart

4

1 reference

14 September 2017

G Peterson

5

1 reference

14 September 2017

J Hughes

6

1 reference

14 September 2017

L White

8

1 reference

14 September 2017

1 August 2011

1 reference

14 September 2017

1 reference

14 September 2017

28

1 reference

14 September 2017

8

1 reference

14 September 2017

987-993

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

14 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03296.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03296.X

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03296.X

Effect of a pharmacist-managed diabetes care program in a free medical clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03296.X

A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03296.X

Diabetes Ten City Challenge: final economic and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03296.X

Community pharmacist-provided extended diabetes care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03296.X

Implementation and evaluation of Australian pharmacists' diabetes care services

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03296.X

Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03296.X

The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03296.X

The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03296.X

Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03296.X

A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03296.X

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03296.X

10.1111/J.1464-5491.2011.03296.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference